Mostrando 4 resultados de: 4
Filtros aplicados
Origen
scopus(4)
Cluster-randomized, crossover trial of head positioning in acute stroke
ArticleAbstract: BACKGROUND The role of supine positioning after acute stroke in improving cerebral blood flow and thPalabras claves:Autores:Arima H., Billot L., Brunser A.M., Cui L., De Silva H.A., Forshaw D., Hackett M.L., Lavados P.M., Lee T.H., Lightbody C.E., Lim J.Y., Lin R.T., Mead G.E., Middleton S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Peng B., Robinson T.G., Rogers K., S Anderson C., Song L., Venturelli P.M., Watkins C.L., Woodward M.Fuentes:scopusInfluence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
ArticleAbstract: Background and Purpose - Renal dysfunction (RD) is associated with poor prognosis after stroke. We aPalabras claves:Glomerular Filtration Rate, Hypertension, intracranial hemorrhages, ODDS RATIO, strokeAutores:Carr S.J., Chalmers J., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Octavio Marques Pontes-Neto, Olavarria V.V., Ricci S., Robinson T.G., Rodriguez J.A., S Anderson C., Sato S., Sharma V.K., Wang X., Woodward M.Fuentes:scopusLow-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)
Conference ObjectAbstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior aPalabras claves:aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activatorAutores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial
ArticleAbstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the stPalabras claves:Autores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopus